Media Summary: Scott Tagawa, MD, MS, FACP, Weill Cornell Medical Center, New York, NY, takes us through a study which evaluated the Kevin Kalinsky, MD, MS, Emory University Hospital, Atlanta, GA, discusses the results of a study looking at real-world Aditya Bardia, MD, MPH, a medical oncologist at Massachusetts General Hospital and assistant professor of medicine at Harvard ...
Efficacy Of Sacituzumab Govitecan By - Detailed Analysis & Overview
Scott Tagawa, MD, MS, FACP, Weill Cornell Medical Center, New York, NY, takes us through a study which evaluated the Kevin Kalinsky, MD, MS, Emory University Hospital, Atlanta, GA, discusses the results of a study looking at real-world Aditya Bardia, MD, MPH, a medical oncologist at Massachusetts General Hospital and assistant professor of medicine at Harvard ... Sara Tolaney, MD, MPH, Dana-Farber Cancer Institute, Boston, MA, discusses the final overall survival (OS) analysis of the Phase ... At this year's European Society for Medical Oncology (ESMO) Congress in Madrid, Spain, Dr. Kevin Kalinsky, Director of the Glenn ... Aditya Bardia, MD, MPH, assistant professor of medicine, Harvard Medical School, attending physician, Medical Oncology, ...
Petros Grivas, MD, PhD, Director of University of Washington Medicine's Genitourinary Cancers Program, talks about the There is a clear need for better therapies to treat triple-negative breast cancer, says Aditya Bardia, breast medical oncologist, ... Stephanie L. Graff, MD, director, Breast Program, Sarah Cannon Cancer Institute, associate director, Breast Cancer Research ... Dr. Bardia on Sacituzumab Govitecan in TNBC Dr Tolaney talks to ecancer about results she presented at ASCO 2025 from an international phase 3 clinical trial that showed that ...
